RAD 140 - PharmaQO

RAD 140 (Testolone) PharmaQO for sale in the UK

RAD 140 by PharmaQO is an oral selective androgen receptor modulator (SARM) — also known as Testolone or by its development name Vosilasarm — favoured by lean-mass and recomposition users who want testosterone-like anabolic activity without the aromatisation, water retention or full DHT side-effect profile of injectable steroids. If you want to buy RAD 140 UK from a verified source, each PharmaQO tub sold here is lab-tested and shipped same working day from our UK warehouse.

What is RAD-140 (Testolone)?

RAD-140 is a non-steroidal SARM originally developed by Radius Health as an oncology candidate (Vosilasarm) for hormone-receptor-positive breast cancer and androgen-deficiency conditions. It binds the androgen receptor with high affinity — pre-clinical work places its anabolic potency at roughly five times that of testosterone on AR-binding assays — but, because it is tissue-selective, the prostatic and sebaceous activity stays much lower than with traditional anabolic steroids. Per Wikipedia, plasma half-life is around 45–60 hours, so once-daily dosing is appropriate (the popular online figure of 16–20 hours is incorrect and over-states required dose frequency). RAD-140 does not aromatise to oestrogen, so no aromatase inhibitor is required, but it still suppresses the HPTA via androgen feedback and is on the WADA prohibited list.

RAD 140 benefits

• Strong lean-mass gains with very little water retention or bloat
• Marked strength increase, often noticeable within 1–2 weeks
• No aromatisation — no oestrogenic side effects, no AI required
• Useful for recomposition cycles where calories are at maintenance
• Oral capsule — no injections, no PIP, no needle protocols

The 10 mg PharmaQO cap allows precise dose titration across the full 5–30 mg/day window without splitting capsules.

RAD 140 dosage and cycle

Beginners: 5–10 mg/day. Intermediate: 10–20 mg/day. Advanced: 20–30 mg/day (suppression and AST/ALT elevation become more pronounced at the top of this range). Cycle length is typically 8 weeks — RAD-140 is potent enough that longer runs are not needed and the hepatic and HPTA cost rises with duration. Because the half-life is 45–60 hours, once-daily dosing in the morning gives stable blood levels. Onset is fast for a SARM: most users report strength changes by week 1–2. RAD-140 is generally not recommended for women due to the residual androgenic potential at performance doses.

Side effects and PCT

RAD-140 is not side-effect free. Expect partial-to-significant testosterone suppression — primate studies show roughly 50% reduction at active doses, and human user reports mirror this, so a full PCT is required after every cycle. Clinical trial data for Vosilasarm shows AST/ALT elevations in 46–59% of subjects, so liver enzyme load is real and a TUDCA/NAC liver-support stack is sensible for the cycle duration. Mild blood-pressure rise, headaches and minor sleep disruption have been reported at higher doses; some users notice mood/aggression changes. RAD 140 does not aromatise, so an aromatase inhibitor is not required. After the cycle, run a SERM-based PCT — Nolvadex (Tamoxifen) or an all-in-one option such as PCT Tabs Pharmaqo are the standard choices to restore endogenous testosterone production.

Stacks well with

RAD 140 is most often run solo at first to gauge response, then layered into recomposition stacks. A common pairing is with Cardarine (GW-501516) for endurance and fat oxidation during a recomp, or with Ostarine MK-2866 for a milder dual-SARM lean-mass cycle. Advanced users sometimes add YK-11 for hardness, though this materially increases suppression and liver load.

Frequently asked questions

How long does RAD 140 take to start working?

Most users notice strength gains and improved gym performance from week 1 to 2, with visible recomposition building through weeks 3 to 6. With a 45–60 hour half-life, blood levels stabilise within the first few days of dosing and once-daily administration is sufficient — there is no benefit to splitting the dose.

Is RAD 140 suitable for first-time users?

Not as a first compound. RAD 140 is one of the strongest SARMs available and produces meaningful HPTA suppression plus measurable liver-enzyme elevation in clinical data. New SARM users are generally better starting with Ostarine, gauging response and committing to a proper PCT, before stepping up to Testolone.

Can RAD 140 be detected on a drug test?

Yes. RAD 140 and its metabolites are screened for under WADA testing protocols and the compound is on the prohibited list. Specific detection windows are not as well-published as for traditional AAS, but anyone subject to sport or workplace drug testing should assume detection is possible for several weeks after the last dose.